The FDA urges caution when prescribing such medications for patients with a history of heart failure, low blood pressure, or uncontrolled high blood pressure
"These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss," Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview included in the Cure report, "maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well." Troubling Pattern in Patient Adherence to GLP-1 Drug Therapy Despite their effectiveness, adhering to the injectable drugs have proven challenging
For long-term storage of unopened vials, the freezer is fine (up to 3 years), but once liquid hits that powder, the fridge is its only home
Smoking-induced OS activates inflammation and initiates ROS production
Understanding the why behind each test deepens your engagement and helps you recognize meaningful improvements